The efficacy and effectiveness of ready-to-use therapeutic food (RUTF) for the treatment of wasting have been previously documented,1,2 and its use as part of community-based treatment of severe acute malnutrition in children is now recommended.3
The article by Isanaka and colleagues4 in this issue of JAMA provides evidence that RUTF distributed for a 3-month period was efficacious in preventing wasting and severe wasting in children aged 6 to 60 months. In this cluster randomized controlled trial of 12 villages in Niger, all families with children aged 6 to 60 months with weight-for-height 80% or more of the National Center for Health Statistics reference standard received 92 g (providing 500 kcal) of RUTF daily for 3 months. The distribution of RUTF during the period of the year with documented food shortages improved weight maintenance among children and reduced wasting by 36% and severe wasting by 58%. This well-designed and implemented study extends current knowledge of RUTF from therapeutic use to the prevention of wasting in a population-based sample. However, whether untargeted distribution of RUTF would be a cost-effective, sustainable intervention compared with other approaches to prevent malnutrition remains to be determined.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.